NCT05170919 2024-09-19
Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
Englewood Hospital and Medical Center
Phase 2 Enrolling by invitation
Clinical Trials
6 trialsNCT03283488 2023-07-07
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
University of Sao Paulo
Phase 2 Completed
NCT05380479 2022-05-18
Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2 Unknown
NCT00832520 2018-04-10
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
New Mexico Cancer Research Alliance
Phase 2 Terminated
NCT02650544 2016-01-08
Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression
Sun Yat-sen University
Phase 2 Unknown
NCT01501396 2014-02-03
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite
Washington University School of Medicine
Phase 2 Withdrawn